Newronika announced today that it received CE mark approval for its AlphaDBS device for treating Parkinson's disease.
Medical Device Network on MSN7d
Enable Injections’ syringe transfer system gains CE mark approvalEnable Injections’ enFuse Syringe Transfer System has secured CE mark approval under the European Union Medical Device ...
Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has ...
Enable Injections announced today that it received CE mark approval for its EnFuse syringe transfer system for drug delivery.
GlobalData on MSN9d
Newronika’s DBS device gains CE Mark approval for Parkinson’s treatmentNewronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback